Effect of blood substitute, recombinant hemoglobin, on in vivo hematopoietic recovery from AZT toxicity

Acta Haematologica

Volumn 98, Issue 2, 1997, Pages 76-82

  Moqattash, Satei ^a   Lutton, John D ^b   Rasenthal, Gary ^c   Abu Hijleh, Marwan F ^a   Abraham, Nader G ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b ROCKEFELLER UNIVERSITY   (United States)

^c BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Azidothymidine; Erythroid burst forming units; Erythropoietin; Recombinant hemoglobin

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE MARROW DEPRESSION; BURST FORMING UNIT E; CONTROLLED STUDY; DRUG TOXICITY; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMATOPOIESIS; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BLOOD SUBSTITUTES; CACHEXIA; DRUG THERAPY, COMBINATION; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; FEMALE; HEMATOPOIESIS; HEMOGLOBINS; HUMANS; MICE; MICE, SCID; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; RECOMBINANT PROTEINS; ZIDOVUDINE;

EID: 0030807034     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203596     Document Type: Article

References (38)

1. Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Slarre HB, Zalusky R, Ables RI, Tsai HC, Rudnik SA: Recombinant human erythropoietin for patients with AIDS treated with azido-vudine. N Engl J Med 1990;322:1488-1492.
2. DaCosta NA, Hultin MB: Effective therapy of human immunodeficiency virus-associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin. AmJHematol 1991;36:71-72.
3. Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA: Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from azidovudine. Blood 1991;77:2109-2117.
4. Beru N, Goldwasser E: The regulation of heme biosynthesis during erythropoietin-induced erythroid differentiation. J Biol Chcm 1985; 260:9251-9257.
5. Abraham NG, Nelson JC, Ahmed TG, Levere RD: Erythropoietin controls heme metabolic enzymes in normal human bone marrow culture. Exp Hematol 1989;17:908-913.
6. Abraham NG, Konwalinka G, Lutton JD, Levere RD, Griffin MO, Shibahara S: Heme modulation of the microenvironment in the regulation of bone marrow growth and differentiation; in Sachs L, Abraham NG, Weidermann C, Levine AS, Konwalinka G (eds): Molecular Biology of Hematopoiesis. Andover, Intercept, 1990, pp 261-272.
7. Novogrodsky A, Tsuji A, Lander H, Stenzel KH: Immune stimulatory and anti-tumor properties of hemin; in Abraham NG, Marks P, Konwalinka G, Sachs L, Tavassoli M (eds): Molecular Biology of Haematopoiesis. Andover, Intercept, 1992, vol 2, p 581.
8. Lu L, Broxmeyer HE: The selective enhancing influence of hemin and products of human erythrocytes on colony formation by human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells in vitro. Exp Hematol 1983;11:721-729.
9. Chertkov JL, Jiang S, Lutton JD, Levere RD, Abraham NG: Heme stimulation of hematopoiesis in murine long-term bone marrow culture. Exp Hematol 1991;19:905-909.
10. Monette FC, Holden SA: Hemin enhances the in vitro growth of primitive erythroid progenitor cells. Blood 1982;60:527-530.
11. Abraham NG, Chertkov JL, Staudinger R, Jiang S, Lutton JD. Argani I, Kappas A, Levere RD: Long-term bone marrow stromal and hematopoietic toxicity to AZT: Protective role of heme and IL-1. Exp Hematol 1993:21:263-268.
12. Prochownik EV: c-myb but not c-myc suppresses the hemin-induced nonterminal expression of hemoglobin by murine erythroleukemia cells. Blood 1989;73:782-786.
13. Griffin MO, Nelson JC, Abraham NG: Early protooncogene expression during hemin-in-duced differentiation of human crythroleu-kernic cells. Leuk Res 1991;14:997-1006.
14. Abraham NG, Konwalinka G, Lutton JD, Levere RD, Griffin MO, Shibahara S: Heme modulation of the microenvironment in the regulation of bone marrow growth and differentiation; in Sachs L, Abraham NG, Wiedermann C, Levine AS, Konwalinka G (eds): Molecular Biology of Hematopoiesis. Andover, Intercept, 1990, vol 1, p 261.
15. Cronkite EP, Bullis J: In vivo toxicity of 3'-azi-do-3'-deoxythymidine (AZT) on CBA/Ca mice. Int J Cell Cloning 1990;8:332-335.
16. Abraham NG, Bucher D, Niranjan U, Brown AC, Lutton JD, Distenfeld A, Ahmed T, Levere RD: Microenvironmental toxicity of azidothy-midine: Partial sparing with hemin. Blood 1989;74:139-144.
17. Fischl MA, Richman DD, Gricco M, Gottlieb MS, Volberdin PA, Laskin OL, Lccdom JJ, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durck D, Kind D, the AZT Collaborative Working Group: The efficacy of 3'-azido-3' deoxythymidine (azidothymidine) in the treatment of patients with AIDS and AIDS-related complex: A double blind, placebo-controlled trial. N Engl J Med 1987;317:185-192.
18. Chow FPR, Hamburger AW: Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice. Exp Hematol 1992;20:245-250.
19. Chow F-PR, Hamburger AW: In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS. Eur J Hematol 1991;47:91-97.
20. Dainiak N, Worthington M, Riordan MA, Kreckzko S, Goldman L: 3'-Azido-3'dcoxythy-midine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 1988;69:299-304.
21. Sommadossi JP, Carlisle R: Toxicity of 3'-azi-do-3' deoxythymidine and 9 (l,3-dihydroxy-2-propoxymethyl) guanine for normal human hematopoietic progenitor cells in vitro. Antimi-crob Agents Chemother 1987;31:452-461.
22. Lutton JD, Mathew A, Levere RD, Abraham NG: Role of heme metabolism in AZT induced bone marrow toxicity. Am J Hematol 1990;35: 1-5.
23. Jolicoeur P: Murine acquired immunodeficiency syndrome (MAIDS): An animal model to study AIDS pathogenesis. FASEB J 1991;5: 2398-2405.
24. Morse HC III, Chattopadhyay SK, Makino M, Fredrickson TN, Hugin AW, Hartly JW: Rctro-virus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS Res 1992; 6:607-621.
25. Moqattash S, Lutton JD, Abu-Hijleh MF, Abraham NG: Hemopoietic recovery from AZT toxicity with recombinant hemoglobin in a murine model of AIDS. Acta Haematol 1994; 92:182-186.
26. Nath KA, Agarwal A, Vogt BA: Functional consequences of induction of heme oxygenase; in Goligorsky MS, Stein JH (eds): Contemporary Issues in Nephrology, Acute Renal Failure. New York, Chuchill Livingstone 1995, pp 3097-3118.
27. Maines MD, Mayer RD, Ewing JF, McCoub-rey WK Jr: Induction of heme oxygenase-1 (HSP32) mRNA and protein by ischemia/ reperfusion: Possible role of heme as both promoter of tissue damage and regulator of HSP32. J Pharmacol Exp Ther 1993;264:457- 462.
28. Loew7 G, Cook P, Ahmed T, Lutton JD, Nishi-mura M, Distenfeld A, Levere RD, Abraham NG: Specificity of heme for hematopoietic recover/ from AZT toxicity. Hematol Pathol 1992;6:79-85.
29. Abraham NG, Lutton JD, Levere RD: The role of heme biosynthesis and degradative enzymes in erythroid colony development: The effect of hemin. Br J Haematol 1982;50:17-28.
30. Lutton JD, Levere RD, Abraham NG: Physiologic role of heme and cytochrome P-450 in hematopoietic cells. Proc Soc Exp Biol Med 1991:167:260-269.
31. Abraham NG, Lutton JD, Levere RD: Eclectic mechanisms of heme regulation of hematopoiesis. Int J Cell Cloning 1991;9:185-210.
32. Abraham NG, Drummond GS, Lutton JD, Kappas A: The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 1996;6:129-168.
33. Abraham NG, Lutton JD, Levere RD: Heme metabolism and erythropoiesis in abnormal iron states: The role of aminolevulinic acid synthetase and heme oxygenase. Exp Hematol 1985;13:838-843.
34. Chertkov JL, Jiang S, Levere RD, Lutton JD, Abraham NG: Hemin stimulation of hematopoiesis in murine long-term bone marrow cultures. Exp Hematol 1991; 19:905-909.
35. Richman DA, Fischl MA, Grieco MH, Gottlieb MS, Voldberding PA, Laski OL, Leedom JM, Groopman JE, Mildvani D, Hirsch MS, Jackson GG, Durack DD, Nusinof-Lebrman S, the AZT collaborative group: The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and IDS related complex: A double-blind placebo controlled trial. N Engl J Med 1987;317:192-197.
36. Ganser A, Greher J, Volkers B, Straszweski S, Hoelzer D: Azidothymidine in the treatment of AIDS. N Engl J Med 1988;318:250-251.
37. Porter PN, Meints RH, Mesner K: Enhancement of erythroid colony growth in culture by hemin. Exp Hematol 1979;7:11-16.
38. Monette FC, Holden SA, Sheehy SA, Matzin-ger EA: Specificity of hemin action in vivo at early stages of hematopoietic cell differentiation. Exp Hematol 1988;16:260-269.